The high activity for fund was in 2018. The fund is constantly included in less than 2 investment rounds annually. The usual things for fund are deals in the range of 10 - 50 millions dollars.
Besides, a startup needs to be aged 2-3 years to get the investment from the fund. Among the most successful fund investment fields, there are Life Science, Biotechnology. Among the various public portfolio startups of the fund, we may underline Glympse Bio
The standard case for the fund is to invest in rounds with 9 partakers. Despite the LS Polaris Innovation Fund, startups are often financed by Biocon, Aspect Ventures. The meaningful sponsors for the fund in investment in the same round are Yonghua Capital, Rivas Capital, Inevitable Ventures.
Related Funds
| Fund Name | Location |
| 20/20 HealthCare Partners | Auburndale, Massachusetts, United States |
| Ashv Finance | India, Maharashtra, Mumbai |
| Associated Bank | Green Bay, United States, Wisconsin |
| Bank Of Canada | Canada, Ontario, Ottawa |
| Canopy Rivers | Canada, Ontario, Toronto |
| J-Ventures | California, Palo Alto, United States |
| Levfam Holdings | - |
| Mendes | - |
| Nazer Group | Jeddah, Makkah, Saudi Arabia |
| PJT Partners | New York, New York, United States |
| Round One Investors | - |
| Stundi | Phuket, Phuket Province, Thailand |
| Surveyor Capital | Chicago, Illinois, United States |
| Telenor Norway | - |
| Tricadia Capital Management | New York, New York, United States |
| Virginia Tech Carilion (VTC) Innovation Fund | Roanoke, United States, Virginia |
| Visionplus | Finland, Helsinki, Southern Finland |
| Wattsense Participations | - |
| Yingchuang Dehong | Chengdu, China, Sichuan |
| Youdu Qiye Guanli Zixun | China, Tianjin, Wuqing |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
QurAlis | $88M | 09 Mar 2023 | Cambridge, Massachusetts, United States | ||
Satellite Bio | $82M | 07 Mar 2022 | Cambridge, Massachusetts, United States | ||
Muna Therapeutics | $73M | 09 Jul 2021 | Copenhagen, Hovedstaden, Denmark | ||
Satellite Bio | $19M | 17 Nov 2020 | Cambridge, Massachusetts, United States | ||
| $46M | 15 Jul 2020 | Cambridge, Massachusetts, United States | |||
QurAlis | $42M | 13 May 2020 | Cambridge, Massachusetts, United States | ||
Glympse Bio | $22M | 09 Oct 2018 | Cambridge, Massachusetts, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
QurAlis | $88M | 09 Mar 2023 | Cambridge, Massachusetts, United States | ||
Satellite Bio | $82M | 07 Mar 2022 | Cambridge, Massachusetts, United States | ||
Muna Therapeutics | $73M | 09 Jul 2021 | Copenhagen, Hovedstaden, Denmark | ||
Satellite Bio | $19M | 17 Nov 2020 | Cambridge, Massachusetts, United States | ||
| $46M | 15 Jul 2020 | Cambridge, Massachusetts, United States | |||
QurAlis | $42M | 13 May 2020 | Cambridge, Massachusetts, United States | ||
Glympse Bio | $22M | 09 Oct 2018 | Cambridge, Massachusetts, United States |
